Abel Hall LLC’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Buy
7,832
+43
+0.6% +$5.94K 0.2% 62
2026
Q2
$1M Sell
7,789
-8,120
-51% -$950K 0.17% 83
2026
Q1
$1.91M Buy
15,909
+4,520
+40% +$522K 0.41% 32
2025
Q4
$1.2M Buy
11,389
+966
+9% +$90.7K 0.28% 47
2025
Q3
$875K Sell
10,423
-47
-0.4% -$3.87K 0.35% 41
2025
Q2
$829K Buy
10,470
+2,451
+31% +$195K 0.38% 41
2025
Q1
$720K Buy
8,019
+3,005
+60% +$281K 0.43% 36
2024
Q4
$499K Sell
5,014
-242
-5% -$24.9K 0.32% 45
2024
Q3
$597K Sell
5,256
-5
-0.1% -$594 0.39% 39
2024
Q2
$651K Buy
5,261
+162
+3% +$20.9K 0.46% 36
2024
Q1
$673K Buy
5,099
+87
+2% +$10.7K 0.5% 33
2023
Q4
$546K Buy
+5,012
New +$520K 0.47% 32

Other funds holding MRK

Abel Hall LLC's MRK Position: Q3 2026 in Review

Abel Hall LLC increased its Merck (MRK) stake by 0.55% in Q3 2026, buying an estimated $5.94K and bringing the position to 7,832 shares worth $1.14M. The position accounts for 0.2% of the portfolio, ranked #62.

Abel Hall LLC first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.91M in Q1 2026. 1,488 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Abel Hall LLC held 7,832 shares of Merck worth $1.14M as of Q3 2026.
  • Abel Hall LLC bought 43 Merck shares in Q3 2026, an estimated $5.94K.
  • Merck made up 0.2% of Abel Hall LLC's portfolio in Q3 2026, its #62 holding.
  • Abel Hall LLC first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • Abel Hall LLC's Merck position peaked at $1.91M in Q1 2026.
  • 1,488 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.